📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
CONCORD DRUGS LIMITEDCONCORDPharmaceuticals
Open
76
High
77
Low
73.61
Close
73.92
Volume
4906
Exchange
bse
Time
12-Mar-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Concord Drugs is  
Long Body
Estimated Stoploss of Concord Drugs is ₹  
77
Concord Drugs has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Concord Drugs maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Concord Drugs is in  
Sideways trendℹ
. 
Price of Concord Drugs is  
Downℹ
 by  

6.32

%. 
Target
Buy @ 

70.36

Sell @ 

90.36

Current @ 

73.92

Volume

The trade volumes of Concord Drugs have become  
Deficientℹ
The volume trend for Concord Drugs is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Concord Drugs is  

Down

 by  

51.4

% 

Valuation

The current market price of Concord Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 65cr and total assets worth ₹ 65cr, the balance sheet of Concord Drugs is:  
Balancedℹ
. 
Cashflow
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 3cr earned in operatingℹ
33.33% i.e. ₹ 2cr spent in investingℹ
16.67% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

0% in operatingℹ
100% i.e. ₹ 1cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Concord Drugs Losses increased by:  

0

% and Income is Down by:  

23.08

% 

(*Sep 2025)

The income of Concord Drugs is  

₹ 13cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

30

% 

(*Jun 2025)

The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.